Who owns Abbvie?
- CUSIP Number: 00287Y909
Tip: Access positions for across all investors
Analyze quarterly positions in Abbvie with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Abbvie stock
Who bought or sold Abbvie this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| IMC-Chicago | 376k | $82M | -6% | Mar 2026 |
|
| Simplex Trading | 193k | $44M | 4% | Dec 2025 |
|
| Group One Trading | 143k | $31M | -28% | Mar 2026 |
|
| Hrt Financial | 82k | $18M | 127% | Mar 2026 |
|
| SG Americas Securities | 60k | $261k | -94% | Mar 2026 |
|
| Gladius Capital Management | 56k | $12M | 49% | Mar 2026 |
|
| Maven Securities | 15k | $3.5M | -53% | Dec 2025 |
|
| Genesis Financial Group | 1.5k | $326k | 100% | Mar 2026 |
|
| National Bank Of Canada /fi/ | 600.00 | $14M | -40% | Dec 2025 |
|
Who sold out of Abbvie?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jpmorgan Chase & Co | Sep 2025 | 267k | $62M |
| Burns Matteson Capital Management | Dec 2025 | 1.0k | $64k |